Faster and better than a physician?: Assessing diagnostic proficiency of ChatGPT in misdiagnosed individuals with neuromyelitis optica spectrum disorder.

J Neurol Sci

The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, TX, USA. Electronic address:

Published: January 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Neuromyelitis optica spectrum disorder (NMOSD) is a commonly misdiagnosed condition. Driven by cost-consciousness and technological fluency, distinct generations may gravitate towards healthcare alternatives, including artificial intelligence (AI) models, such as ChatGPT (Generative Pre-trained Transformer). Our objective was to evaluate the speed and accuracy of ChatGPT-3.5 (GPT-3.5) in the diagnosis of people with NMOSD (PwNMOSD) initially misdiagnosed.

Methods: Misdiagnosed PwNMOSD were retrospectively identified with clinical symptoms and time line of medically related events processed through GPT-3.5. For each subject, seven digital derivatives representing different races, ethnicities, and sexes were created and processed identically to evaluate the impact of these variables on accuracy. Scoresheets were used to track diagnostic success and time to diagnosis. Diagnostic speed of GPT-3.5 was evaluated against physicians using a Cox proportional hazards model, clustered by subject. Logistical regression was used to estimate the diagnostic accuracy of GPT-3.5 compared with the estimated accuracy of physicians.

Results: Clinical time lines for 68 individuals (59 female, 42 Black/African American, 13 White, 11 Hispanic, 2 Asian; mean age at first symptoms 34.4 years (y) (standard deviation = 15.5y)) were analyzed and 476 digital simulations created, yielding 544 conversations for analysis. The instantaneous probability of correct diagnosis was 70.65% less for physicians relative to GPT-3.5 within 240 days of symptom onset (p < 0.0001). The estimated probability of correct diagnosis for GPT-3.5 was 80.88% [95% CI = (76.35%, 99.81%)].

Conclusion: GPT-3.5 may be of value in recognizing NMOSD. However, the manner in which medical information is conveyed, combined with the potential for inaccuracies may result in unnecessary psychological stress.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2024.123360DOI Listing

Publication Analysis

Top Keywords

neuromyelitis optica
8
optica spectrum
8
spectrum disorder
8
gpt-35
5
faster better
4
better physician?
4
physician? assessing
4
diagnostic
4
assessing diagnostic
4
diagnostic proficiency
4

Similar Publications

We present the case of a 54-year-old patient treated with cemiplimab, an immune checkpoint inhibitor (ICI), for multiple basal cell carcinomas in the context of Gorlin Goltz syndrome. Gorlin Goltz syndrome is an autosomal dominant multisystem disorder characterized, among other features, by multiple early-onset basal cell carcinomas (BCCs). After receiving Cemiplimab, she developed aquaporin-4 antibody (AQP4-Ab) positive neuromyelitis optica spectrum disorder (NMOSD).

View Article and Find Full Text PDF

Headache in optic neuritis: A retrospective case-control study revealing clinical and radiological associations of an underrecognized symptom.

Mult Scler Relat Disord

September 2025

Neurologist-Neuroimmunologist. Associate Professor of Neurology, Neuroscience Department, Division of Neurology, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia. Electronic address:

Background: Headache is a common but underrecognized symptom in optic neuritis (ON), with potential implications for diagnosis and management.

Objective: To assess the clinical and radiological factors associated with headache in patients with acute ON.

Methods: We conducted a retrospective case-control study in a tertiary hospital in Bogotá, Colombia (2022-2024).

View Article and Find Full Text PDF

Objective: Soluble interleukin-2 receptor (sIL-2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) pathogenesis. However, sIL-2R has so far not been evaluated in these conditions.

View Article and Find Full Text PDF

Unlabelled: Neutrophils and neutrophil extracellular traps (NETs) contribute to early neuromyelitis optica (NMO) histopathology initiated by IgG targeting astrocytic aquaporin-4 water (AQP4) channels. Yet, the mechanisms recruiting neutrophils and their pathogenic roles in disease progression remain unclear. To investigate molecular-cellular events preceding classical complement cascade activation in a mouse NMO model, we continuously infused, via spinal subarachnoid route, a non-complement-activating monoclonal AQP4-IgG.

View Article and Find Full Text PDF

Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing autoimmune disease of the central nervous system (CNS). Management during pregnancy is challenging due to limited safety data for disease-modifying therapies. We report a case of a 41-year-old woman with aquaporin-4 (AQP4) IgG positive NMOSD who was switched from rituximab to ravulizumab during pregnancy.

View Article and Find Full Text PDF